Amwell names new CFO: 5 things to know 

Amwell appointed Robert Shepardson to serve as its new CFO and head of mergers and acquisitions, effective Oct. 31. 

Advertisement

Five things to know: 

1. Mr. Shepardson will work alongside Amwell’s current CFO, Keith Anderson, through the end of 2021, the telehealth company said in a Sept. 21 news release. 

2. Mr. Shepardson brings more than 30 years of investment banking and capital markets experience to the role, in which he will oversee Amwell’s finance, accounting, and mergers and acquisitions efforts. 

3. He most recently served as Morgan Stanley’s global capital markets managing director and held several leadership positions in global markets and media and communications investment banking at the company. 

4. As managing director of Morgan Stanley’s global capital markets, Mr. Shephardson was responsible for all equity issuance in the healthcare vertical and led financings for multiple companies including Amwell, One Medical and Oak Street Health. 

5. Mr. Anderson will remain CFO of Amwell through Oct. 16 and then transition to a full-time advisory role through 2021.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.